Targeted copper radiation tested in kids with tough cancer
Disease control
Terminated
This study tested a personalized radiation therapy called 67Cu-SARTATE in children with high-risk neuroblastoma, a serious childhood cancer. The goal was to find the safest and most effective dose and see if it could help control the cancer. The trial was designed to adapt treatm…
Phase: PHASE1, PHASE2 • Sponsor: Clarity Pharmaceuticals Ltd • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC